IL144916A0 - Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone - Google Patents

Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone

Info

Publication number
IL144916A0
IL144916A0 IL14491600A IL14491600A IL144916A0 IL 144916 A0 IL144916 A0 IL 144916A0 IL 14491600 A IL14491600 A IL 14491600A IL 14491600 A IL14491600 A IL 14491600A IL 144916 A0 IL144916 A0 IL 144916A0
Authority
IL
Israel
Prior art keywords
bromoepiandrosterone
hemihydrate
immunomodulatory
steroids
alpha
Prior art date
Application number
IL14491600A
Other languages
English (en)
Original Assignee
Holis Eden Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holis Eden Pharmaceuticals Inc filed Critical Holis Eden Pharmaceuticals Inc
Publication of IL144916A0 publication Critical patent/IL144916A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL14491600A 1999-03-23 2000-03-23 Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone IL144916A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12605699P 1999-03-23 1999-03-23
US14002899P 1999-06-16 1999-06-16
US41490599A 1999-10-08 1999-10-08
US16404899P 1999-11-08 1999-11-08
PCT/US2000/007883 WO2000056757A1 (en) 1999-03-23 2000-03-23 Immunomodulatory steroids, in particular the hemihydrate of 16.alpha.-bromoepiandrosterone

Publications (1)

Publication Number Publication Date
IL144916A0 true IL144916A0 (en) 2002-06-30

Family

ID=27494614

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14491600A IL144916A0 (en) 1999-03-23 2000-03-23 Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone

Country Status (22)

Country Link
EP (1) EP1163256B1 (enExample)
JP (1) JP2002540119A (enExample)
KR (2) KR20070007394A (enExample)
CN (1) CN1243767C (enExample)
AP (1) AP2001002285A0 (enExample)
AT (1) ATE259825T1 (enExample)
AU (1) AU781997B2 (enExample)
BR (1) BR0009476A (enExample)
CA (1) CA2365081A1 (enExample)
CZ (1) CZ20013420A3 (enExample)
DE (1) DE60008353T2 (enExample)
DK (1) DK1163256T3 (enExample)
ES (1) ES2215631T3 (enExample)
HK (1) HK1046002B (enExample)
HU (1) HUP0203429A3 (enExample)
IL (1) IL144916A0 (enExample)
NO (2) NO320801B1 (enExample)
NZ (1) NZ513803A (enExample)
OA (1) OA11850A (enExample)
PT (1) PT1163256E (enExample)
RU (2) RU2417792C2 (enExample)
WO (1) WO2000056757A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070129282A1 (en) 1998-11-24 2007-06-07 Ahlem Clarence N Pharmaceutical treatments and compositions
US6667299B1 (en) 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
EP1228083A2 (en) 1999-09-30 2002-08-07 Hollis-Eden Pharmaceuticals Inc. Therapeutic treatment of androgen receptor driven conditions
US7241753B2 (en) 2000-02-25 2007-07-10 Loria Roger M Method of treatment of prostate cancer
EP1372664A1 (en) 2001-03-01 2004-01-02 Hollis-Eden Pharmaceuticals Inc. Use of certain steroids for treatment of blood cell deficiencies
FR2829697B1 (fr) * 2001-09-14 2004-03-19 Mayoly Spindler Lab Derives 7-hydroxyles et 7-cetoniques des hormones steroides 3 beta-hydroxylees pour le traitement des maladies inflammatoires ou fonctionnelles de l'intestin
US20040138187A1 (en) * 2002-08-28 2004-07-15 Reading Christopher L. Therapeutic treatment methods
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
RU2356555C2 (ru) * 2003-12-26 2009-05-27 Ниссан Кемикал Индастриз, ЛТД Антинейтрофильное средство
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
CN104072564B (zh) * 2013-03-28 2016-08-17 广州市赛普特医药科技股份有限公司 2β,3α,5α-三羟基-雄甾-6-酮及其制备方法与用途
CN106565654B (zh) * 2016-10-14 2018-08-31 云南中烟工业有限责任公司 一种从白云参中提取的新型黄酮类化合物、其制备方法及其用途
BR112020021278A2 (pt) * 2018-06-01 2021-01-26 Société des Produits Nestlé S.A. butirato dietário
US10836788B2 (en) 2019-02-05 2020-11-17 SD Chem, Inc. Aqueous suspension compositions, formulations, and water dispersible dry compositions comprising 16alpha-bromo-3beta-hydroxy-5alpha-androstan-17-ketone and hydrates, derivatives, and analogs thereof
AU2020398693A1 (en) * 2019-12-05 2022-04-28 Société des Produits Nestlé S.A. Dietary butyrate
CN114907333B (zh) * 2022-05-11 2023-07-04 中国人民解放军军事科学院军事医学研究院 环丙甲酰胺衍生物及其制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH197784A (de) * 1934-05-25 1938-05-15 Schering Kahlbaum Ag Verfahren zu Darstellung von D5,6-trans-Androstendiol-3,17.
ES8706717A1 (es) * 1983-08-02 1987-07-01 Research Corp Metodo de preparar esteroides
NL194728C (nl) * 1987-04-16 2003-01-07 Hollis Eden Pharmaceuticals Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan.
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
JPH0289327A (ja) * 1988-09-27 1990-03-29 Matsushita Electron Corp 銀ペースト塗布装置
US5837269A (en) * 1989-09-25 1998-11-17 University Of Utah Research Foundation Vaccine compositions and method for enhancing an immune response
IE60458B1 (en) * 1989-10-26 1994-07-13 Elan Corp Plc Enhanced bioavailability adsorbates

Also Published As

Publication number Publication date
NZ513803A (en) 2004-06-25
EP1163256A1 (en) 2001-12-19
HUP0203429A2 (hu) 2003-01-28
CN1243767C (zh) 2006-03-01
KR100717897B1 (ko) 2007-05-14
HK1046002B (zh) 2006-10-20
DE60008353T2 (de) 2005-09-08
NO20014588D0 (no) 2001-09-21
RU2417792C2 (ru) 2011-05-10
ATE259825T1 (de) 2004-03-15
JP2002540119A (ja) 2002-11-26
HUP0203429A3 (en) 2004-07-28
CN1355809A (zh) 2002-06-26
RU2001128881A (ru) 2003-09-27
CA2365081A1 (en) 2000-09-28
NO20056167L (no) 2001-11-21
RU2295534C2 (ru) 2007-03-20
DE60008353D1 (de) 2004-03-25
HK1046002A1 (en) 2002-12-20
KR20020003217A (ko) 2002-01-10
AP2001002285A0 (en) 2001-12-31
DK1163256T3 (da) 2004-06-28
WO2000056757A1 (en) 2000-09-28
EP1163256B1 (en) 2004-02-18
BR0009476A (pt) 2002-02-19
AU3919000A (en) 2000-10-09
KR20070007394A (ko) 2007-01-15
CZ20013420A3 (cs) 2002-04-17
AU781997B2 (en) 2005-06-23
NO320801B1 (no) 2006-01-30
PT1163256E (pt) 2004-07-30
ES2215631T3 (es) 2004-10-16
NO20014588L (no) 2001-11-21
RU2006133273A (ru) 2008-03-27
OA11850A (en) 2006-03-06

Similar Documents

Publication Publication Date Title
GB2349340B (en) Auxiliary erotic implement
IL146223A0 (en) Steroid derivatives
HUP0400646A3 (en) Steroid hormone-compositions and processes for their preparation
AU5208401A (en) 3-nitrogen-6,7-dioxygen steroids and uses related thereto
EP1231835A4 (en) CHANGE OF FLOWERING TIME
IL144916A0 (en) Immunomodulatory steroids, in particular the hemihydrate of 16-alpha-bromoepiandrosterone
GB0013206D0 (en) Parallel-gripping chuck
IL149715A0 (en) MICROBIAL 9α-HYDROXYLATION OF STEROIDS
IL144455A0 (en) 16-hydroxyestratrienes as selective estrogens
GB9930390D0 (en) Releasable fasteners
GB2352661B (en) Chuck
EP1150628A4 (en) CONDOM
EP1238799A4 (en) PLASTIFIER MACHINE
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
GB0011191D0 (en) Chuck
AU5326400A (en) Sulfated sterol derivatives and processes for preparing the same
GB0028576D0 (en) Cabin
GB9917200D0 (en) Building component
AU2003600A (en) External steroid preparation
GB9921851D0 (en) Structural elements
GB9926508D0 (en) Improved fittings
GB2368544B (en) chuck
GB9903424D0 (en) Gull wing
GB9903163D0 (en) Building component
GB9927615D0 (en) Airship

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees